Control of Heparin in Pharmaceuticals and Substances
Chromogenic methods according to the Russian Pharmacopoeia XIII and the European Pharmacopoeia 8.0: A) Renaparin test: Reagent kit for determining anti-Xa and anti-IIa activity of low-molecular-weight heparin; B) Renaparin-NFG test: Reagent kit for determining anti-Xa and anti-IIa activity of unfractionated heparin.
Clotting methods according to the Russian Pharmacopoeia XIII: Reagents for determining the activity of unfractionated heparin:
Reagent kit for determining sodium citrate in anticoagulants.
Determination of the activity of plasma preparations
Clotting methods for determining the activity of coagulation factors: A) Substrate-deficient plasmas for: — Factor II, — Factor VII, — Factor VIII, — Factor IX, — Factor X. B) Coagulo-test; C) Renamplastin.
Reagent kit for determining the activity of antithrombin III.
Reagent kit for determining the concentration of fibrinogen.
Reagent kit for determining the activity of thrombin.
Working Standard Samples of Activity